1. Methylation of H3K27 and H3K4 in key gene promoter regions of thymus in RA mice is involved in the abnormal development and differentiation of iNKT cells
   Ming Meng et al, 2019, Immunogenetics CrossRef
2. Clinico-Biological Implications of Modified Levels of Cytokines in Chronic Lymphocytic Leukemia: A Possible Therapeutic Role
   Alessandro Allegra et al, 2020, Cancers CrossRef
3. High M-MDSC Percentage as a Negative Prognostic Factor in Chronic Lymphocytic Leukaemia
   Michał Zarobkiewicz et al, 2020, Cancers CrossRef
4. Immune Dysfunctions and Immune-Based Therapeutic Interventions in Chronic Lymphocytic Leukemia
   Valentina Griggio et al, 2020, Front. Immunol. CrossRef
5. Translating Unconventional T Cells and Their Roles in Leukemia Antitumor Immunity
   Nilberto Dias de Araújo et al, 2021, Journal of Immunology Research CrossRef
6. Unravelling soluble immune checkpoints in chronic lymphocytic leukemia: Physiological immunomodulators or immune dysfunction
   Alicia Landeira-Viñuela et al, 2022, Front. Immunol. CrossRef
7. Effects of Interferon-γ and Interleukin-4 on Proliferating Cell Nuclear Antigen Expression in Transplanted Bone Tumor Tissue
   Jiaxing Lv et al, 2023, Int J Pept Res Ther CrossRef
8. Concentration of cytokines (IL-4, IL-12, IFNg) in the blood plasma and its association with lymphocyte apoptosis in patients suffering from chronic lymphocytic leukemia
   Hristina Dejanović et al, 2023, Srpski medicinski časopis Lekarske komore CrossRef